Dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
Details for Australian Patent Application No. 2004280090 (hide)
International Classifications
Event Publications
18 May 2006 PCT application entered the National Phase
PCT publication WO2005/034940 Priority application(s): WO2005/034940
17 April 2008 Alteration of Name
The name of the applicant has been altered to IMTM GmbH; KeyNeurotek Pharmaceuticals AG
13 August 2009 Application Accepted
Published as AU-B-2004280090
10 December 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser